Castrate-resistant Prostate Cancer (CRPC) Market Share, Size, Segmentation Analysis, Key segments and Forecast 2035
The global castrate-resistant prostate cancer (CRPC) market is on a robust growth trajectory from 2025 to 2035, driven by rising prostate cancer incidence, increased adoption of next-generation hormonal agents, and expanding access to precision oncology. CRPC represents a critical clinical stage in prostate cancer progression—occurring when tumors advance despite...
0 Commentarii 0 Distribuiri 68 Views